Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zetomipzomib in Active Lupus Nephritis (Phase II, China)
CTR20240905Phase 2Terminated
- Sponsor
- Not applicable
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zetomipzomib in lupus nephritis (LN), sponsored by Not applicable. Started Mar 2024; status: terminated.
02
Drugs
zetomipzomib
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on CTR20240905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240905.